|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.45B 5.07B 4.66B 8.79B 598B 8.93B 59.77B 23.46B 298B 23.53B 23.02B 999B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.29B 4.93B 4.52B 8.54B 581B 8.68B 58.09B 22.8B 289B 22.87B 22.37B 971B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +2.35% | ||
| 6 months | +60.78% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 15.01 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 28/02/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 31/03/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 23/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 23/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/06/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -19,963,157 | 12.9020% | |
| 01/05/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 02/02/26 | Free | Chief Financial Officer | 226,000 | 0.1691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +140.93% | +476.10% | 6.27B | |
| +1.09% | +1.47% | +0.35% | +15.84% | 48.53B | |
| -2.41% | -0.90% | +411.96% | +472.09% | 39.87B | |
| -1.16% | +12.96% | +28.81% | +7.27% | 38.68B | |
| -1.88% | -3.03% | +5.69% | +66.52% | 35.13B | |
| -1.74% | +5.12% | +14.44% | +44.64% | 29.79B | |
| -0.21% | -4.04% | +36.40% | +126.06% | 16.11B | |
| -2.85% | -3.92% | - | - | 16.08B | |
| +1.14% | +2.72% | +3.31% | +16.75% | 13.61B | |
| -1.19% | -1.32% | -1.73% | -34.97% | 12.62B | |
| Average | -0.70% | +1.14% | +71.13% | +132.26% | 25.67B | |
| Weighted average by Cap. | -0.76% | +2.03% | +81.79% | +117.78% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.04 12.14 11.14 21.04 1.43K 21.37 143.06 56.15 712.87 56.33 55.1 2.39K |
| Net income | -236M -205M -191M -175M -331M -22.51B -336M -2.25B -882M -11.2B -885M -866M -37.57B | -198M -172M -160M -147M -277M -18.86B -281M -1.88B -739M -9.39B -742M -726M -31.48B |
| Net Debt | -364M -317M -295M -271M -511M -34.78B -519M -3.48B -1.36B -17.32B -1.37B -1.34B -58.06B | -176M -153M -143M -131M -247M -16.82B -251M -1.68B -660M -8.37B -662M -647M -28.08B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
